Search results for sanofi-aventis
Live video webcast at 9 a.m (Paris Time) in French with simultaneous translation in English and live audio webcast at 3 p.m (Paris Time) in English. The successive Speakers will be: Mr. Gérard Le Fur
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced that Russia has chosen inactivated polio vaccine (IPV) from Sanofi Pasteur for primary immunization of all infants. The IPV do
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Sanofi-aventis announced that the European Commission has granted competition law clearance to the proposed acquisition of Zentiva NV (Zentiva) by sanofi-aventis Europe. Sanofi-aventis welcomes this
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY), has announced the signing of an agreement with the Mexican authorities to build a € 100 million facility to manufacture influenza vaccine in Mexico. The
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced that its pandemic influenza vaccine for human use Emerflu®, has been granted marketing authoriza
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) has signed a binding agreement for the acquisition of BiPar Sciences, Inc., ("BiPar") a privately held US biopharmaceutical company, developing novel tu
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that Sanofi-Aventis Deutschland GmbH has purchased from Pfizer the Diabel manufacturing plant in Frankfurt-Höchst, Germany, one of the largest s
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) has announced that the results of the long-term, 5-year study of Lantus® (insulin glargine [rDNA] injection) versus NPH insulin on progression of retinopa
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental bi
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced an exclusive global licensing agreement with The Rockefeller University (New York, NY) concerning a novel monoclonal antibody, targeting certain
read more »
Add this link to...
Bury
Add to:
| Bookmarks